David Ratliff

David Ratliff

David Ratliff is an internationally sought-after educator, arranger, clinician, adjudicator and guest conductor. Currently he serves as Director of Bands at Madison Southern High School in Berea, Kentucky.

He is an active participant in the Percussive Arts Society, Kentucky Music Educators Association and Phi Beta Mu. Additionally, he serves as an endorser and clinician for Yamaha Corporation of America, Innovative Percussion Drum Sticks & Mallets as well as Evans Drumheads.

Early Life and Education

Early childhood is incredibly important for a child’s development. Brain connections are especially strong during these months, providing children with invaluable learning that will last throughout life.

Scientists and psychologists have developed theories based on these formative experiences that have significantly shaped education today. Some of the most influential theories include:

Teachers and parents can use these theories to help children learn and flourish. Additionally, they provide a framework for creating an instructional style tailored specifically for each psychosocial stage of development.

Investing in early childhood education is a vital investment for a child’s future health and happiness. Studies show that children who have attended quality pre-school, preschool, or kindergarten programs tend to achieve greater academic success, have fewer health issues, higher employment rates, lower levels of crime, and a greater sense of wellbeing than their peers who didn’t take advantage of such programs.

Professional Career

David Ratliff is a highly regarded expert in the treasury and capital markets space with over 15 years of experience. At Kaufman Hall, he provides clients with advice on a wide range of complex financial matters such as capitalization planning, bond issuance and derivative transactions, risk allocation strategies and asset/liability management.

He takes great pride in his extensive health care industry knowledge, having served as CEO of HUYA Bioscience International and Chief Financial Officer for Quintiles – one of the world’s largest providers of product development and integrated health care services. He continues to lead several entrepreneurial endeavors such as Remarque Systems and Undercover Colors while serving on the ISyE Advisory Board.

Achievements and Honors

David Ratliff is the CEO of Covance Drug Development, a world-renowned drug development firm. Additionally, he sits on the Boards of Directors for HUYA Bioscience International and Remarque Systems, which provides risk-based monitoring software solutions.

He has received several honors, including the John F. Kennedy Profile in Courage Award which recognizes an American public figure who lives by certain principles.

He served in the Texas Senate, where he spearheaded passage of a landmark law to modernize public education in the state. Furthermore, he championed medical malpractice patients’ rights.

Personal Life

David Ratliff is an orthopedic surgeon with expertise in trauma surgery and soft tissue disorders. He also has extensive experience performing arthroscopic and minimally invasive surgical procedures.

He is affiliated with Camc Teays Valley Hospital Inc and Charleston Area Medical Center in Hurricane, West Virginia and board certified in orthopaedics and sports medicine.

His practice involves treating patients with injuries to the shoulder, elbow and hand. He specializes in microsurgery, reconstructive surgery and fracture treatment.

His patients have consistently given him positive reviews. They state that he pays attention to their needs and answers all questions thoroughly; consequently, many have recommended him to others.

Net Worth

David Ratliff is a highly sought-after financial professional. With more than two decades in the industry, he has served as head of financial institutions coverage for Asia-Pacific at BNP Paribas and worked with Citigroup before joining Wells Fargo to lead their banking and capital markets activities in Hong Kong.

David Ratliff had a net worth of $21.8 million as of 11 November 2004. He is an experienced banker in the industry and has extensive knowledge about the Asia Pacific market. He owns substantial amounts of AGCO stock and has made several trades in it; most recently he sold 287,886 units for $5,636,808 on 8 March 2005. To view all his trading history, click on the link provided.

Leave a Reply

Your email address will not be published. Required fields are marked *